chrisvoncsefalvay/vaers-outcomes huggingface dataset:
We have some Moderna Covid-019 vaccine that was given after the expiration date.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (We have some Moderna Covid-019 vaccine that was given after the expiration date.) in a 78-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 091D21A) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (We have some Moderna Covid-019 vaccine that was given after the expiration date.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (We have some Moderna Covid-019 vaccine that was given after the expiration date.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   no concomitant and treatment drugs were provided. Date the vial was initially stored in the refrigerator: 24Sept2021 o*Date(s) of administration of vaccine: 24Oct2021 - 27Oct2021   This case was linked to MOD-2021-374935 (Patient Link).
felt lightheaded; This spontaneous case was reported by a patient and describes the occurrence of DIZZINESS (felt lightheaded) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (felt lightheaded). At the time of the report, DIZZINESS (felt lightheaded) outcome was unknown.            Concomitant information was not provided. Treatment information was not provided.
DEATH DUE TO CANCER OF THE BRAIN. RIGHT AFTER THE 2ND VACCINE, BLOOD PRESSURE SPIKES OF 200 BPM.
She developed a DVT seemingly out of nowhere in her L lower leg, she has never had a DVT before
Child given vaccines Fri. 4/29/11. Mom reported redness to us on Monday & we saw child 5/2/11- local vaccine reaction 6cm long 8.5 cm wide. BENADRYL given. Pt better 5/4/11.
chills; felt icky; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration from an unspecified date at a SINGLE DOSE for covid-19 immunization. The patient's medical history and concomitant medications were not reported. Historical vaccine included BNT162B2 for covid-19 immunization (1st dose). The patient experienced chills and felt icky on an unspecified date after the second dose. The outcome of event was unknown.  Follow-up attempts are completed. The following information on the batch number has been requested.
pt recvd vax; 2 hrs later, began crying;stopped for "breather";would not drink; apap given 5-6 hrs p/ vax; stopped crying 1 hr p/ apap adm;
Patient's entire top 1/2 of arm swelled up and was extremely tender and painful from 2/18 until the morning of 2/20.
Was working and had a minor twisting injury to spine that has occurred occasionally in the past. However, it was one week post vaccine and it seemed as if the vaccine was attacking the areas of inflamation with a vengeance and it developed into an extreme pain syndrome of the lower back and pelvis region radiating down my right leg to my knee. Pain and symptoms lasted approx. 6 weeks. The pain was so bad I had trouble walking and standing. As advised by GP, Endocrinologist, Oncologist, and Orthopedist I seeked chiropractic relief x 3 visits, physical therapy x approx 6 visits, and finally accupuncture approx 6 visits before relief. Additionally I was advised by GP to take high dose Prednisone 40-30-25-20-15-10-5x3ea
Patient had syncopal episode after vaccination. Patient received both vaccinations in the same arm (given one inch apart from one another). Patient noted that the first vaccination (Gardasil 9) hurt more than previous vaccinations. Soon after second vaccination, patient reported feeling lightheaded and soon after, experienced syncope, in her seat. She was still seated at the time of syncope, and did not fall out of her chair. She regained consciousness within seconds, but was not fully alert and oriented, so I asked her to lie down on her back, with her legs elevated on the chair. She then asked for water and a Gatorade protein pack (a snack container with meat, cheese, and nuts) from the front end of the store, and an icepack for her head. She was provided with all of those and soon said she felt fine and left. She reported that she had never had any reaction to any other vaccine, and stated that before the syncopal episode, she felt that "her cervix was burning and her organs were tingling". The next day, she stated that her arm was very sore, especially when lifting it.
I have a, constant, have had ringing in my ear, non-stop; anatomical location and route of administration, consumer stated, "It was the left shoulder."; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 52-year-old male patient received BNT162b2 (BNT162B2), on 09Apr2021 as dose 2, single (Lot number: EW0150) at the age of 50 years for covid-19 immunisation. The patient's relevant medical history included: "Joint pain" (unspecified if ongoing), notes: Joint pain. The patient's concomitant medications were not reported. Vaccination history included: BNT162b2 (DOSE 1, SINGLE; Lot number: ER2613), administration date: 16Mar2021, when the patient was 50-year-old, for Covid-19 immunization, reaction(s): "ringing in his ears", "increasingly harder for him to hear". The following information was reported: TINNITUS (non-serious), outcome "unknown", described as "I have a, constant, have had ringing in my ear, non-stop"; PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (non-serious), outcome "unknown", described as "anatomical location and route of administration, consumer stated, "It was the left shoulder."  Additional information: Consumer stated that he had written a letter this morning about reporting his adverse reaction which he had for quite a while now and he just thought he would report and see if there was anything that can be done on any kind of reaction to the COVID-19 Vaccines (clarified as Pfizer COVID-19 Vaccine). He received the Vaccine 2 the couple of years ago when it first came out. He got the Booster, he got the 2 shots and a Booster, and he had a constant ringing in his ear non-stop. He went to his Physician, and he also spoke with his allergist, and they both have come to the conclusion that it was Tinnitus. He wanted to know if there was anything that Pfizer was doing for people that had adverse reactions to this vaccine. He was having constant ringing in both ears all the time. He was querying what Pfizer was doing for the patients that were having the same problem as he was. He read articles that he was not the only one experiencing this particular issue. When probed for the start date of the side effect, consumer stated that he got it after his first vaccine. It was like a week after that (25Mar2021). When probed for the anatomical location and route of administration, consumer stated that it was the left shoulder. For other medical condition, consumer stated that he doesn't have any hypertension or blood pressure. HE had joint pain, but that was it. When probed for medication for joint pain, consumer stated that there was no medication. He could not continue the medication (Further clarification unknown). Patient did not have any vaccination prior to the first COVID shot. Consumer also asked if he still need to call the medical info, because it was not really much to keep him out of his pain, he just needed to  know what happens next.
Generalized seizure lasting approx. 45 minutes; began with right arm and leg; after 1-2 min., spread to entire body; fell asleep shortly after seizure stopped; no fever during seizure; admitted to ER in hospital 3/5, discharged 3/7; became febrile while in hospital, treated with TYLENOL. 4/10/06 Received medical records from PCP which revealed patient was taking TYLENOL on day of vax.  F/U visit 4 days after vax parent stated patient had seizure 2 hrs after vax.   4/20/06 Received medical records from hospital which revealed patient had tonic-clonic seizure on left side of body in ER lasting approx 30 min.  Fever 102.7.  Petecchaie on right arm.  Admitted overnight.  All c/s & MRI neg, CT of brain neg. LP had hazy CSF.  Hospital does not have any records of a neuro consult being done in hospital/ss Per 60 day follow up report: Recipient has not recovered. Please see 2nd VAERS report submitted 4/22/06; he has had approximately 30 seizures since his first on 3/5/05, with the last occurring on 5/10/06; diagnosed with epilepsy May, 2005. Developmental delayed approx. 5-8 mos.; has been on medication since May, 2005.  Follow-up - Since the adverse event on 3/5/05, pt has had approx. 60 seizures, has bees on various medicationa since May 2005, and has experienced developmental, cognitive, speech, and motor delays.
got my second shot 3 weeks after the first dose; This spontaneous case was reported by a patient and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (got my second shot 3 weeks after the first dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (got my second shot 3 weeks after the first dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (got my second shot 3 weeks after the first dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. No treatment details were provided.   Reporter did not allow further contact
Arm was just tender at first but then woke up with 6 x6 in reddened area that was hot to the touch and very tender.  Looked to have petechiae.  Complained of some shortness of breath, but no wheezing and no sign of airway being compromised.
Received her first dose of Moderna Vaccine 3/30/2021. About 10 minutes post vaccination patient begin to feel dizzy, experienced blurred vision, and cold sweats.  Temp 98.6 BP 108/68 Emergency medical response was called. Patient was given a bottle of water and replaced face mask with a face shield. I continued to monitor patient until EMS arrived. Second BP 128/98 About 20 minutes post vaccination patient stated she was no longer having sweats and vision was returning to normal. EMS arrived and triaged patient. Patient was able to stand and take a few steps. Patient decided she was OK to go home. I walked with patient and EMS to the car (her husband was driving). Patient seemed alert, aware and in good spirit.
ON 4/21/21, SHE BEGAN TO EXPERIENCE SHORTNESS OF BREATH, COUGHING, CONGESTION, SEVERE BACK ACHE, WEAKNESS, FATIGUE,  FEVER, CHILLS, VOMITING, DIARRHEA. I TOOK HER TO THE HOSPITAL WHERE WE WERE TOLD THAT IT WAS DUE TO VACCINE AND SHE WAS SENT HOME WITHOUT MEDS. SHE BECAME WORSE AND WORSE AND DEVELOPED HEART ATTACK SYMPTOMS: CHEST PAIN, WHEEZING, TIGHTNESS AND HEAVINESS IN CHEST, INTENSE BACK PAIN. WE RETURNED TO THE ER AND SHE WAS DIAGNOSED WITH PERICARDITIS. WE WERE ALSO TOLD THAT HER HEART WAS SLIGHTLY ENLARGED.
Temperature of 103 F, very hot and cold. Had a seizure. Was given Motrin/Tylenol for 4 days. Went to the hospital. Was losing color and couldn't breathe. She was given oxygen.
side effects; Hand muscles are weak after second shot; Trouble holding things in his hands after second shot; Dropsy after second shot; Fever 101.7F unresponsive to Excedrin  after second shot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (side effects), MUSCULAR WEAKNESS (Hand muscles are weak after second shot), LIMB DISCOMFORT (Trouble holding things in his hands after second shot), SWELLING (Dropsy after second shot) and PYREXIA (Fever 101.7F unresponsive to Excedrin  after second shot) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002F21A and 052C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Aug-2021, the patient experienced MUSCULAR WEAKNESS (Hand muscles are weak after second shot), LIMB DISCOMFORT (Trouble holding things in his hands after second shot), SWELLING (Dropsy after second shot) and PYREXIA (Fever 101.7F unresponsive to Excedrin  after second shot). On an unknown date, the patient experienced VACCINATION COMPLICATION (side effects). The patient was treated with ACETYLSALICYLIC ACID, CAFFEINE, PARACETAMOL (EXCEDRIN EXTRA STRENGTH) for Fever, at a dose of Extra Strength. At the time of the report, VACCINATION COMPLICATION (side effects), MUSCULAR WEAKNESS (Hand muscles are weak after second shot), LIMB DISCOMFORT (Trouble holding things in his hands after second shot), SWELLING (Dropsy after second shot) and PYREXIA (Fever 101.7F unresponsive to Excedrin  after second shot) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101.7 (High) 101.7F.         No concomitant medications were provided by the reporter.   This case was linked to MOD-2021-290928 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 18-Aug-2021: FU received on 18-AUG-2021 contains no new information
This spontaneous report as received from a medical assistant refers to a female patient of unknown age. There was no concurrent conditions, medical history, allergy/drug reactions and concomitant medications. On 13-OCT-2011, the patient was vaccinated with the first dose of GARDASIL lot #291AA, expiry: 12-APR-2014 (dosing details was not reported). The second dose of GARDASIL lot # and expiry were not reported), was administered on 15-DEC-2011 and the third dose of GARDASIL lot# 1561AA, expiry : 26-AUG-2014 was administered on 19-APR-2012. After the series the patient developed a rash and complained of body discomfort. As of 2015, the symptoms had progressed to joint pain and lower back pain. Primary reporter was requesting lot check for the GARDASIL (lot #291AA, expiry: 12-APR-2014 and lot# 1561AA, expiry: 26-AUG-2014). The patient sought medical attention which included an office visit. There were no lab tests done. No treatment was given for the events. The outcome of the events was unknown. The reporter did not provide the causality between the events and the suspect therapy. There were no product quality complaints (PQC) involved. Additional information has been requested.
Myalgia, Fever, temp 102.8 Narrative:  would have stayed home from work for these symptoms, was off at the time
Pallor, weakness, hypotension, syncope, seizure, anxiety, nausea, dizziness, pain at the injection site.
This spontaneous report as received from a nurse refers to the patient of unknown age and gender. The patients' pertinent medical history and drug reactions or allergies were not reported. On 17-OCT-2017 the patient was vaccinated with an expired dose of M-M-R II subcutaneous (lot # L032181, expiration date 25-AUG-2017, dose and route of administration were not reported) for prophylaxis. Reconstituted with sterile diluent (STERILE DILUENT). The patient did not experienced any adverse events. Product quality complaint was not involved.
chills, temp 100, muscle pain, nausea, headache, fatigue  Rest, kept hydrated, time.  Feeling much better today 3/12/21.  I slept all day 3/11/21.
Initial report received from a health care professional on 09 February 2012. A male patient received 0.5 milliliter (ml) injection (route and site not reported) of INFLUENZA VACCINE (reported as FLUVIRIN but was later corrected to be FLUZONE), sanofi pasteur Inc. lot number not reported, on an unknown date. The patient also received a pneumococcal vaccine (manufacturer and lot number not reported) earlier that day. The patient complained of chest tightness and numbness/tingling in the mouth. The outcome was not reported. Documents held by sender: None.
MMRV given at 90 degree angle with 5/8 inch needle. No adverse symptoms, no treatment given.
received 2nd dose of Moderna COVID vaccine in the morning, started having dizziness, shortness of breath, chest tightness at 3:00PM. BP was 179/101, HR-115, Temp-98.3, O2 Sat-98%, RR-28, complaining of hot flashes and sweating. Taken to the emergency room.
Headache; This is a spontaneous report from a non-contactable consumer (patient) received via COVAES. A 37-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), via an unspecified route of administration, administered in left arm, on 13Feb2021 at 11:15 AM (Batch/Lot number was not reported) (at the age of 37 years old) as dose number unknown, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient was not diagnosed with COVID-19 prior to vaccination and has not been tested for COVID-19 since the vaccination. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced headache on 13Feb2021 at 01:00 PM. The patient has taken acetaminophen as treatment for the event. The patient recovered from headache on an unspecified date in Feb2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
MMRV was advised to repeat dose due to a temperature excursion that was not identified due to not alarming the datalogger. It was the day after we had a longer excursion and was found that our MMRV was no longer viable. After the first excursion the MMRV vaccine had a change in the expiration date. The second excursion was only for 15minutes
Itchy changing to painful rash worsening to appearance of burn. Scabs formed. Mainly inside fold of left elbow. Some scabs on upper left and upper right arm.
pt had 2 episodes of uncontrolled muscle contractions which lasted 15-30seconds per episode;negative loss of bowel, bladder or oral lesions sustained;
Patient presented to the pharmacy on 7/8/2019 at approximately 2:15 pm to show a rash as a result of the Shingrix vaccination. The rash was round and red and about 3 inches in diameter.  The patient complained of itchiness and warmth in the area of the rash, but no pain. This rash showed up at some time on 7/6/2019 after receiving the shot on the afternoon of 7/5/2019.  The patient stated the rash had not grown in size since it appeared.  No additional adverse events were reported. The patient was advised to call her PCP and report the event and see if any office visit or medications were needed.
Body pain in which I could not move within 12 hours EXACTLY after injection. (1/12/2022) lasted 36 hours  Hair loss the next time I washed my hair (2/4/2022) Dizziness and fatigue (1/12/2022)
Information has been received from a registered nurse concerning a 13 year old female patient who on 10/04/99, was vaccinated with a 2nd dose of Hepatitis B vaccine recombinant. A family member of the patient indicated that the following symptoms occurred "right after the vaccination: jaundice, dark circles under eyes, and pain in the ribs." These events were reported to the nurse at the patient's visit on 06/22/00. First the patient's family member stated the symptoms last 2 weeks and then then changed the length of time to one month. Additional information has been requested.
After the initial dose, I noticed my tinnitus worsened -- higher pitch and louder.  It improved before the second dose.  After the second dose, it again immediately worsened and I have noticeably worse tinnitus still. I now have severe tinnitus.  The effects came on quickly.
Site: Pain at Injection Site-Mild, Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting/ responsive-Medium, Additional Details: Pt fainted due to vaccine. Was responsive 1 minute after fainting. Woke up and stayed prone on ground until EMS arrival.
This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Breathing got labor), PAIN (The whole body hurt), DIZZINESS (Felt dizzy) and PYREXIA (A Fever) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concurrent medical conditions included Non-smoker and Abstains from alcohol. Concomitant products included VITAMINS NOS for an unknown indication.On 23-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient experienced DYSPNOEA (Breathing got labor), PAIN (The whole body hurt), DIZZINESS (Felt dizzy) and PYREXIA (A Fever). At the time of the report, DYSPNOEA (Breathing got labor), PAIN (The whole body hurt), DIZZINESS (Felt dizzy) and PYREXIA (A Fever) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.It was reported that the patient do not do drugs (unspecified). Patient went to medical center and had a breath treatment. This case was linked to MOD-2021-435933, MOD-2021-435966 (Patient Link).
Hives/Six days later, the patient ended up with hives all over the body/Severe hives; Tingling in the tongue; Onset of feeling dizzy/Feeling woozy; This spontaneous case was reported by a dietician and describes the occurrence of URTICARIA (Hives/Six days later, the patient ended up with hives all over the body/Severe hives), PARAESTHESIA ORAL (Tingling in the tongue) and DIZZINESS (Onset of feeling dizzy/Feeling woozy) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) and FEXOFENADINE HYDROCHLORIDE (ALLEGRA [FEXOFENADINE HYDROCHLORIDE]) from 06-Jan-2022 to an unknown date for an unknown indication.   On 06-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In January 2022, the patient experienced URTICARIA (Hives/Six days later, the patient ended up with hives all over the body/Severe hives), PARAESTHESIA ORAL (Tingling in the tongue) and DIZZINESS (Onset of feeling dizzy/Feeling woozy). The patient was treated with PREDNISONE for Adverse event, at a dose of 40 mg. At the time of the report, URTICARIA (Hives/Six days later, the patient ended up with hives all over the body/Severe hives), PARAESTHESIA ORAL (Tingling in the tongue) and DIZZINESS (Onset of feeling dizzy/Feeling woozy) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient was pre medicated with Zyrtec right before the vaccine. The patient stated that next day, she had onset of feeling dizzy and woozy, tingling in the tongue and had other things 3 days later.   This case was linked to MOD-2021-027034 (Patient Link).